These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9685833)

  • 1. MR and magnetisation transfer imaging in cirrhotic and fatty livers.
    Alanen A; Komu M; Leino R; Toikkanen S
    Acta Radiol; 1998 Jul; 39(4):434-9. PubMed ID: 9685833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetization transfer in fatty and low-fat livers.
    Komu M; Alanen A
    Physiol Meas; 1994 Aug; 15(3):243-50. PubMed ID: 7994202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetization transfer contrast imaging of liver cirrhosis.
    Chen JH; Chai JW; Shen WC
    Hepatogastroenterology; 1999; 46(29):2872-7. PubMed ID: 10576364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Zhong L; Chen JJ; Chen J; Li L; Lin ZQ; Wang WJ; Xu JR
    J Dig Dis; 2009 Nov; 10(4):315-20. PubMed ID: 19906112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of intrahepatic lipids using fat-selective imaging with spectral-spatial excitation and in-/opposed-phase gradient echo imaging techniques within a study population of extremely obese patients: feasibility on a short, wide-bore MR scanner.
    Springer F; Machann J; Schwenzer NF; Ballweg V; Würslin C; Schneider JH; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2010 Aug; 45(8):484-90. PubMed ID: 20479651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy.
    Levenson H; Greensite F; Hoefs J; Friloux L; Applegate G; Silva E; Kanel G; Buxton R
    AJR Am J Roentgenol; 1991 Feb; 156(2):307-12. PubMed ID: 1898804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans.
    Mitchell DG; Kim I; Chang TS; Vinitski S; Consigny PM; Saponaro SA; Ehrlich SM; Rifkin MD; Rubin R
    Invest Radiol; 1991 Dec; 26(12):1041-52. PubMed ID: 1765436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging.
    Borra RJ; Salo S; Dean K; Lautamäki R; Nuutila P; Komu M; Parkkola R
    Radiology; 2009 Jan; 250(1):130-6. PubMed ID: 19017926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
    Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
    Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience.
    Qayyum A; Goh JS; Kakar S; Yeh BM; Merriman RB; Coakley FV
    Radiology; 2005 Nov; 237(2):507-11. PubMed ID: 16244259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
    Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
    Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging.
    Westphalen AC; Qayyum A; Yeh BM; Merriman RB; Lee JA; Lamba A; Lu Y; Coakley FV
    Radiology; 2007 Feb; 242(2):450-5. PubMed ID: 17255416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats.
    Okada M; Katsube T; Kumano S; Kagawa Y; Araki T; Tsuda N; Okuaki T; Imaoka I; Tanigawa N; Ishii K; Murakami T
    Acta Radiol; 2011 Jul; 52(6):658-64. PubMed ID: 21498305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
    Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
    J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging.
    Martín J; Sentís M; Zidan A; Donoso L; Puig J; Falcó J; Bella R
    Radiology; 1995 Apr; 195(1):125-30. PubMed ID: 7892452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo magnetic resonance (MR) study of fatty liver: importance of intracellular ultrastructural alteration for MR tissue parameters change.
    Chai JW; Lin YC; Chen JH; Wu CC; Lee CP; Chu WC; Lee SK
    J Magn Reson Imaging; 2001 Jul; 14(1):35-41. PubMed ID: 11436212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.
    Friedrich-Rust M; Müller C; Winckler A; Kriener S; Herrmann E; Holtmeier J; Poynard T; Vogl TJ; Zeuzem S; Hammerstingl R; Sarrazin C
    J Clin Gastroenterol; 2010 Jan; 44(1):58-65. PubMed ID: 19581812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetization transfer contrast-prepared MR imaging of the liver: inability to distinguish healthy from cirrhotic liver.
    Rosenkrantz AB; Storey P; Gilet AG; Niver BE; Babb JS; Hajdu CH; Lee VS
    Radiology; 2012 Jan; 262(1):136-43. PubMed ID: 22114240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of fatty liver with MR imaging.
    Kreft BP; Tanimoto A; Baba Y; Zhao L; Chen J; Middleton MS; Compton CC; Finn JP; Stark DD
    J Magn Reson Imaging; 1992; 2(4):463-71. PubMed ID: 1633400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.